(0.13%) 5 187.70 points
(0.08%) 38 884 points
(-0.10%) 16 333 points
(-0.14%) $78.37
(1.09%) $2.22
(-0.37%) $2 322.50
(-0.49%) $27.48
(2.39%) $988.00
(0.16%) $0.930
(0.76%) $10.91
(0.43%) $0.799
(0.11%) $91.45
-2.60% $ 3.00
@ $0.410
Emitido: 12 feb 2024 @ 16:00
Retorno: 631.71%
Live Chart Being Loaded With Signals
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases...
Stats | |
---|---|
Volumen de hoy | 37 734.00 |
Volumen promedio | 74 825.00 |
Capitalización de mercado | 65.35M |
EPS | $0 ( 2024-04-02 ) |
Próxima fecha de ganancias | ( $-0.140 ) 2024-05-27 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.290 |
ATR14 | $0.0160 (0.53%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-13 | Fletcher Kyle | Sell | 20 | Class A Common Stock |
2024-04-13 | Haines John R | Sell | 576 | Class A Common Stock |
2024-04-13 | Beers David C | Sell | 360 | Class A Common Stock |
2024-04-13 | Hariri Robert J | Sell | 1 154 | Class A Common Stock |
2024-04-13 | Brigido Stephen | Sell | 268 | Class A Common Stock |
INSIDER POWER |
---|
57.11 |
Last 98 transactions |
Buy: 89 262 897 | Sell: 26 354 903 |
Volumen Correlación
Celularity Inc. Correlación
10 Correlaciones Más Positivas | |
---|---|
ASPS | 0.945 |
AUID | 0.931 |
PROG | 0.93 |
CLFD | 0.93 |
AYLA | 0.927 |
OP | 0.927 |
JUPW | 0.925 |
ADP | 0.925 |
AMD | 0.925 |
PCSA | 0.925 |
10 Correlaciones Más Negativas | |
---|---|
CBAY | -0.935 |
TIOA | -0.926 |
CITE | -0.922 |
BWC | -0.915 |
XPDB | -0.915 |
BRIV | -0.914 |
TIOAU | -0.914 |
ROCL | -0.914 |
ITAQ | -0.912 |
MPRA | -0.912 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Celularity Inc. Correlación - Moneda/Commodity
Celularity Inc. Finanzas
Annual | 2022 |
Ingresos: | $17.98M |
Beneficio Bruto: | $-1.69M (-9.40 %) |
EPS: | $1.010 |
FY | 2022 |
Ingresos: | $17.98M |
Beneficio Bruto: | $-1.69M (-9.40 %) |
EPS: | $1.010 |
FY | 2021 |
Ingresos: | $21.34M |
Beneficio Bruto: | $17.69M (82.90 %) |
EPS: | $-12.49 |
FY | 2020 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.0215 |
Financial Reports:
No articles found.
Celularity Inc.
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-001, placental-derived unmodified natural killer (NK) cell that is in Phase I clinical trial to treat acute myeloid leukemia, as well as in Phase I/IIa clinical trial for the treatment of glioblastoma multiforme and COVID-19; CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I clinical trial to treat HER2+ gastric and gastroesophageal cancers; APPL-001, a placenta-derived mesenchymal-like adherent stromal cell that is in a pre-clinical stage for the treatment of Crohn's disease; and PDA-002, a placenta-derived mesenchymal-like adherent stromal cell, which is in pre-clinical stage for the treatment of facioscapulohumeral muscular dystrophy. It also sells and licenses products that are used in surgical and wound care markets, such as Biovance and Interfyl; collects stem cells from umbilical cords and placentas; and provides cells storage under the LifebankUSA brand. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico